उत्पाद या दवाइयाँ जिनमें All you wanted to know about Remdesivir है

संदर्भ

  1. US Food and Drug Administration (FDA) [internet]. Maryland. US; Fact Sheet for Patients And Parent/Caregivers Emergency Use Authorization (EUA) Of Remdesivir For Coronavirus Disease 2019 (COVID-19)
  2. Science Direct (Elsevier) [Internet]; Nucleosides
  3. National Human Genome Research Institute [Internet]. Bethesda (MD): National Institute of Health. U.S.A.; Nucleotide
  4. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Nucleoside Analogues. [Updated 2013 Mar 28].
  5. Amiriana E. Susan, Levy Julie K. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses. One Health. 2020 Jun; 9: 100128. PMID: 32258351.
  6. Grein J., et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. NEJM. 2020 April.
  7. National Institute of Allergies and Infectious diseases [internet]: National Institute of Health. US Department of Health and Human Services; NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19
  8. Gilead Sciences Inc. [Internet]. California. US; Remdesivir Clinical Trials
  9. Wang Yeming, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial The Lancet. 2020 April.
  10. The Center for Evidence Based Medicine: University of Oxford [Internet]. Oxford. UK; Lopinavir/ritonavir: A rapid review of effectiveness in COVID-19
  11. World Health Organization [Internet]. Geneva (SUI): World Health Organization; Landscape analysis of therapeutics as 21st March 2020
ऐप पर पढ़ें